These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 9408217)

  • 41. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dopaminergic mediation of the stimulant generalization of nicotine.
    Schechter MD; Meehan SM
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Sep; 17(5):835-45. PubMed ID: 7902994
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine.
    Gaiardi M; Gubellini C; Dall'Olio R; Gandolfi O; Bartoletti M
    Behav Pharmacol; 2001 Sep; 12(5):317-24. PubMed ID: 11710746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.
    Corrigall WA; Robertson JM; Coen KM; Lodge BA
    Pharmacol Biochem Behav; 1992 Jan; 41(1):165-9. PubMed ID: 1539067
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of nimodipine on the discriminative stimulus properties of d-amphetamine in rats.
    Nencini P; Woolverton WL
    Psychopharmacology (Berl); 1988; 96(1):40-4. PubMed ID: 3147476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.
    Li M; Wessinger WD; McMillan DE
    J Exp Anal Behav; 2005 Jul; 84(1):77-97. PubMed ID: 16156138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discriminative stimulus effects of intravenous l-nicotine and nicotine analogs or metabolites in squirrel monkeys.
    Takada K; Swedberg MD; Goldberg SR; Katz JL
    Psychopharmacology (Berl); 1989; 99(2):208-12. PubMed ID: 2508155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences between alcohol-preferring and alcohol-nonpreferring rats in ethanol generalization.
    McMillan DE; Li M; Shide DJ
    Pharmacol Biochem Behav; 1999 Oct; 64(2):415-9. PubMed ID: 10515323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
    Goudie AJ; Dubicki W; Leathley M
    J Pharm Pharmacol; 1988 Mar; 40(3):192-6. PubMed ID: 2899149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nornicotine is self-administered intravenously by rats.
    Bardo MT; Green TA; Crooks PA; Dwoskin LP
    Psychopharmacology (Berl); 1999 Oct; 146(3):290-6. PubMed ID: 10541729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. (-)-Norpseudoephedrine, a metabolite of cathinone with amphetamine-like stimulus properties, enhances the analgesic and rate decreasing effects of morphine, but inhibits its discriminative properties.
    Nencini P; Fraioli S; Pascucci T; Nucerito CV
    Behav Brain Res; 1998 Apr; 92(1):11-20. PubMed ID: 9588681
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of difference between HAD and LAD rats in the stimulus generalization of ethanol to nicotine.
    McMillan DE; Li M
    Behav Pharmacol; 1999 Dec; 10(8):809-12. PubMed ID: 10780297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of (+)-fenfluramine on 3,4-methylenedioxymethamphetamine (MDMA) discrimination in rats.
    Baker LE; Makhay MM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):455-61. PubMed ID: 8808158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nornicotine pretreatment decreases intravenous nicotine self-administration in rats.
    Green TA; Phillips SB; Crooks PA; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2000 Oct; 152(3):289-94. PubMed ID: 11105939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intranucleus accumbens amphetamine infusions enhance responding maintained by a stimulus complex paired with oral ethanol self-administration.
    Slawecki CJ; Samson HH; Chappell A
    Pharmacol Biochem Behav; 1997 Dec; 58(4):1065-73. PubMed ID: 9408215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing food deprivation relative to baseline influences D-amphetamine dose-response gradients.
    Lotfizadeh AD; Zimmermann ZJ; Watkins EE; Edwards TL; Poling A
    Pharmacol Biochem Behav; 2014 Oct; 125():65-69. PubMed ID: 25179163
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethanol does not affect discriminative-stimulus effects of nicotine in rats.
    Le Foll B; Goldberg SR
    Eur J Pharmacol; 2005 Sep; 519(1-2):96-102. PubMed ID: 16109399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal parameters of d-amphetamine as a discriminative stimulus in the rat.
    Jones CN; Grant LD; Vospalek DM
    Psychopharmacologia; 1976; 46(1):59-64. PubMed ID: 1257368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.